Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Haipeng Tang , Shaojie Tang , Weihua Zhou Added: 3 years ago
Cardiac resynchronisation therapy (CRT) is a widely-performed standard treatment for improving cardiac function and quality of life in patients with heart failure.1 After CRT, however, 30–40 % of patients do not experience improvements in left ventricular (LV) function and clinical symptoms.2–3 The key factors for increasing the response rate to CRT are identification of the optimal LV lead… View more
Job title: Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine
Dr Federico Asch is the Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine (Cardiology) at Georgetown University. His research interests are: Myocardial viability in Ischemic Cardiomyopathy, Devices in Cardiovascular Diseases, Role of Echocardiography in clinical trials, and Contrast Echocardiography.a View more
Roxy Senior is Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist and Director of Echocardiography at the Royal Brompton Hospital, London and Northwick Park Hospital, Harrow. He is a clinician with a major interest in echocardiography. He has been involved with echocardiography for the last 25 years and has published… View more
Author(s): Emmanuel Koutalas , Borislav Dinov , Sergio Richter , et al Added: 3 years ago
Since the introduction of electroanatomical mapping (EAM) into clinical practice in 1997, remarkable progress has been made in catheter infrastructure, signal recording and processing, catheter guidance and visualisation and simultaneous real-time depiction and processing of different types of critical information during an ablation procedure.1 The latter, along with the comprehension of the… View more
Author(s): Nicolas Johner , Mehdi Namdar , Dipen Shah Added: 3 years ago
Catheter ablation (CA) is a widely used first-line treatment for AF. Randomised controlled trials (RCTs) have shown its superiority to pharmacological treatment in terms of symptom control, rhythm control and mortality in selected patients; observational studies have also suggested a decreased risk of stroke.1,2 Pulmonary vein isolation (PVI) is the standard endpoint, but studies have reported… View more
Prof Divaka Perera is a Professor of Interventional Cardiology in the School of Cardiovascular Medicine & Sciences and an Honorary Cardiologist at Guy’s and St Thomas’ Hospital. He graduated in medicine from Cambridge University, undertook cardiology specialist training in London and Sussex and received a Clinical Senior Lectureship Award from the Higher Education Funding Council for England in… View more
Author(s): Zhao Liu , J Kevin Donahue Added: 3 years ago
In the United States, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia affecting approximately six million patients and contributing to a greatly increased risk of stroke, heart failure (HF) and overall morbidity and mortality.1,2 The prevalence of AF is increasing as the average age of the population increases.3,4 Currently available therapies for AF are suboptimal… View more